SCHEMBL2804482

SCHEMBL2804482

CCCCCCCCC1=CCC([SiH3])=C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 3/20 0.37
ESR1 P03372 2/20 0.37
ADRA2A P08913 2/20 0.37
ADORA3 P0DMS8 2/20 0.37
TACR2 P21452 2/20 0.37
SLC6A2 P23975 2/20 0.37
SLC6A4 P31645 2/20 0.37
SLC6A3 Q01959 2/20 0.37
ACHE P22303 2/20 0.37
TP53 P04637 2/20 0.37
CYP3A4 P08684 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
SHBG P04278 1/20 0.37
HSPD1 P10809 1/20 0.37
ADRB3 P13945 1/20 0.37
HTR2C P28335 1/20 0.37
HSPE1 P61604 1/20 0.37
HIF1A Q16665 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6250287 0.78 PTGS2 (0.38) PTGS2ESR1ADRA2AADORA3TACR2
SCHEMBL6253785 0.78 PTGS2 (0.38) PTGS2ESR1ADRA2AADORA3TACR2
SCHEMBL6253058 0.78 PTGS2 (0.38) PTGS2ESR1ADRA2AADORA3TACR2
Hydrochloric Acid SCHEMBL8397551 0.77 PTGS2 (0.37) PTGS2ESR1ADRA2AADORA3TACR2
SCHEMBL6254553 0.77 ACHE (0.34) PTGS2ESR1ADRA2AADORA3TACR2
SCHEMBL6254706 0.77 ACHE (0.34) PTGS2ESR1ADRA2AADORA3TACR2
SCHEMBL6250217 0.76 PTGS2 (0.36) PTGS2ESR1ADRA2AADORA3TACR2
Hydrochloric Acid SCHEMBL27794748 0.76 ACHE (0.33) PTGS2ESR1ADRA2AADORA3TACR2
SCHEMBL27446595 0.74 PTGS2 (0.35) PTGS2ESR1ADRA2AADORA3TACR2
Hydrochloric Acid SCHEMBL6675000 0.73 PTGS2 (0.34) PTGS2ACHECYP3A4LIPGBACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2218725-B1 BRIDGED METALLOCENE OLEFIN POLYMERIZATION CATALYST AND ETHYLENE POLYMER OBTAINED BY USING THE CATALYST MITSUI CHEMICALS INC (JP) 2013-10-23 EP disclosed
US-20100292421-A1 BRIDGED METALLOCENE COMPOUND, OLEFIN POLYMERIZATION CATALYST CONTAINING THE SAME, AND ETHYLENE POLYMER OBTAINED WITH THE CATALYST MITSUI CHEMICALS, INC. 2010-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292421-A1 BRIDGED METALLOCENE COMPOUND, OLEFIN POLYMERIZATION CATALYST CONTAINING THE SAME, AND ETHYLENE POLYMER OBTAINED WITH THE CATALYST CAD, ENDOD1, CCT7 PTGS2 555/4885ESR1 369/4885ADRA2A 2776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.